Deals, Partnering

Odyssey Thera in collaboration with Mitsubishi Tanabe Pharma for analysis of drug candidates

Posted on 15 May 2009

Tags: ,

Odyssey Thera will apply its patented Protein-fragment Complementation Assay (PCA), proprietary High Context Screening infrastructure, unique institutional knowledge, and state-of-the-art data analysis strategies in the collaboration to yield valuable insights related to drug selectivity, safety, and mechanisms of action. Financial terms of the collaboration were not disclosed.

Print Friendly, PDF & Email

Leave a Reply